2016 Lebanese society of infectious diseases and clinical microbiology guidelines on the management of febrile neutropenia in adult cancer patients in the era of growing antimicrobial resistance
Joint Authors
Maghniyah, Rima
Matar, Madonna J.
Mokhbat, Jacques
Yared, Nadine
Abd Allah, Daniayh
Atawi, Rula
Choucair, Jacques
Dakdouki, Ghenwa
Farra, Anna
al-Hulw, Gilbert
Hammud, Jamal
Awn, Naji
Kanj, Suha S.
Husni, Rula
Jaradah, Muna
al-Awar, Ghassan
Abi Hanna, Pierre
Kanafani, Zaynah A.
Source
Issue
Vol. 65, Issue 2 (30 Jun. 2017), pp.63-82, 20 p.
Publisher
Publication Date
2017-06-30
Country of Publication
Lebanon
No. of Pages
20
Main Subjects
Abstract EN
Febrile neutropenia is common in cancer patients managed with chemotherapy.
Many published international guidelines have included detailed recommendations on the management of various aspects of febrile neutropenia seen in this population.
Various factors play a role in the management of febrile neutropenia in cancer patients including, local microbiology epidemiology, availability of diagnostic tests and available antimicrobial agents on the local market.
On behalf of the Lebanese Society of Infectious Diseases and Clinical Microbiology, the panel members hope that the guidelines on the management of infections in patients with febrile neutropenia in an era of rising antimicrobial resistance will help health care providers standardize the care of these patients.
Abstract FRE
La neutropénie fébrile est une complication fréquente après un traitement anticancéreux.
Des directives internationales ont été publiées concernant les recommandations détaillées traitant cette complication.
Cependant, lorsqu’un médecin est confronté à un patient, beaucoup de facteurs affectent la décision de prise en charge, y compris l’épidémiologie bactérienne locale, le profil de résistance aux antimicrobiens ainsi que la disponibilité des tests diagnostiques et des agents antimicrobiens sur le marché local.
Les membres de la Société Libanaise des Maladies Infectieuses et Microbiologie Clinique ont mis en place des recommandations pour la prise en charge de la neutropénie fébrile chez les sujets immunodéprimés à l’ère de l’augmentation des taux de résistance aux antimicrobiens.
Ces directives visent à aider les médecins libanais dans le traitement des patients à haut risque.
American Psychological Association (APA)
Maghniyah, Rima& Farra, Anna& al-Hulw, Gilbert& Hammud, Jamal& Awn, Naji& Kanj, Suha S.…[et al.]. 2017. 2016 Lebanese society of infectious diseases and clinical microbiology guidelines on the management of febrile neutropenia in adult cancer patients in the era of growing antimicrobial resistance. Journal Médical Libanais،Vol. 65, no. 2, pp.63-82.
https://search.emarefa.net/detail/BIM-760857
Modern Language Association (MLA)
Farra, Anna…[et al.]. 2016 Lebanese society of infectious diseases and clinical microbiology guidelines on the management of febrile neutropenia in adult cancer patients in the era of growing antimicrobial resistance. Journal Médical Libanais Vol. 65, no. 2 (2017), pp.63-82.
https://search.emarefa.net/detail/BIM-760857
American Medical Association (AMA)
Maghniyah, Rima& Farra, Anna& al-Hulw, Gilbert& Hammud, Jamal& Awn, Naji& Kanj, Suha S.…[et al.]. 2016 Lebanese society of infectious diseases and clinical microbiology guidelines on the management of febrile neutropenia in adult cancer patients in the era of growing antimicrobial resistance. Journal Médical Libanais. 2017. Vol. 65, no. 2, pp.63-82.
https://search.emarefa.net/detail/BIM-760857
Data Type
Journal Articles
Language
English
Notes
Includes appendices p. : 76-82
Record ID
BIM-760857
